By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cerexa, Inc. 

2100 Franklin Street
Suite 900
Oakland  California  94612  U.S.A.
Phone: 510-285-9200 Fax: 510-747-3940


Company News
Forest Laboratories, Inc. (FRX) Announces Completion of Acquisition Of Cerexa, Inc. 1/12/2007 8:38:12 AM
The Day In Review: Forest Laboratories, Inc. (FRX) Buys Cerexa, Inc. For $480 Million 12/15/2006 12:25:33 PM
Cerexa, Inc. Expands Portfolio Of Novel Anti-Infective Therapies Through In-Licensing Agreement With Meiji Seika Kaisha, Ltd. 11/1/2006 12:24:23 PM
Cerexa, Inc. Release: Phase 2 Study Shows Ceftaroline Highly Efficacious In Treatment Of cSSSI Compared To Standard Therapy 9/29/2006 2:11:06 PM
Cerexa, Inc. Reports Positive Top-Line Results For Phase 2 Clinical Trial Of Ceftaroline 8/2/2006 10:23:45 AM
Cerexa, Inc. Appoints George H. Talbot, M.D., Chief Medical Officer, Executive Vice President 7/28/2006 10:39:52 AM
Cerexa, Inc. Announces Completion Enrollment In Ceftaroline Phase 2 Trial 4/5/2006 10:24:09 AM
FDA Grants Cerexa, Inc. Fast Track Designation For PPI-0903 3/14/2006 10:31:17 AM
East Bay Biotechs Hit Sales Block 1/3/2006 11:44:06 AM
Cerexa, Inc. To Present At Credit Suisse First Boston Healthcare Conference 11/15/2005 12:19:49 PM